GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Search

BioArctic AB

Closed

290 -7.29

Overview

Share price change

24h

Current

Min

272.2

Max

312.8

Key metrics

By Trading Economics

Income

-979M

97M

Sales

-897M

392M

P/E

Sector Avg

25.665

35.733

EPS

1.09

Profit margin

24.623

Employees

119

EBITDA

1.1B

1.1B

Market Stats

By TradingEconomics

Market Cap

6.6B

27B

Previous open

297.29

Previous close

290

BioArctic AB Chart

Past performance is not a reliable indicator of future results.

Related News

5 Sept 2025, 16:09 UTC

Acquisitions, Mergers, Takeovers

BBVA Clears Last Hurdle to Open $17.4 Billion Bid to Sabadell Shareholders -- 2nd Update

5 Sept 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

5 Sept 2025, 20:37 UTC

Acquisitions, Mergers, Takeovers

Blue Water: Assets of Auction Include Nationwide Retail Distribution Network of More Than 4,000 Branded Service Stations >BLUWU

5 Sept 2025, 20:37 UTC

Acquisitions, Mergers, Takeovers

Blue Water: Assets of Auction Include Lubricant and Blending Plants Supporting Specialty Fuels and Lubricants >BLUWU

5 Sept 2025, 20:36 UTC

Acquisitions, Mergers, Takeovers

Blue Water: Assets of Auction Include Midstream Infrastructure, Including Pipelines and Terminals Such as the Sour Lake Crude Pipeline >BLUWU

5 Sept 2025, 20:36 UTC

Acquisitions, Mergers, Takeovers

Blue Water: Assets of Auction Include Refineries at Lake Charles, La., Lemont, Ill., Corpus Christi, Texas, With Combined Refining Capacity Exceeding 800,000 Barrels per Day >BLUWU

5 Sept 2025, 20:33 UTC

Acquisitions, Mergers, Takeovers

Blue Water: Proposal Would Provide $3.2B Settlement for Holders of PDVSA 2020 Bonds to Be Paid Either in Cash or in Shrs of Publicly Listed Entity That Will Own Citgo >BLUWU

5 Sept 2025, 20:33 UTC

Acquisitions, Mergers, Takeovers

Blue Water: Proposal Would Provide Cash or Stk Distributions to PDV Holding Inc.'s General Creditors >BLUWU

5 Sept 2025, 20:31 UTC

Acquisitions, Mergers, Takeovers

Blue Water Acquisition Corp. III: Announces Submission of $10B Bid for PDV Holding Inc., Parent of Citgo Petroleum Corp.

5 Sept 2025, 20:20 UTC

Earnings

These Stocks Moved the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

5 Sept 2025, 19:23 UTC

Market Talk

Oil Futures Extend Losses Ahead of OPEC+ Meeting -- Market Talk

5 Sept 2025, 19:22 UTC

Earnings

Week's Best: Insurance Costs, Like Sea Levels, Are Rising -- Barrons.com

5 Sept 2025, 19:17 UTC

Market Talk

U.S. Natural Gas Snaps Winning Streak -- Market Talk

5 Sept 2025, 18:59 UTC

Earnings

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

5 Sept 2025, 18:35 UTC

Market Talk

BMO Leans Toward September Canada Rate Cut After 'Exceptionally Weak' Jobs Report -- Market Talk

5 Sept 2025, 17:25 UTC

Market Talk

Bets on Hefty Fed Cut Seen as Exaggerated -- Market Talk

5 Sept 2025, 17:20 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 414 -- Market Talk

5 Sept 2025, 17:17 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 Sept 2025, 17:17 UTC

Market Talk

Bank of Canada Policy Seen Moving to Expansionary Territory -- Market Talk

5 Sept 2025, 17:03 UTC

Market Talk

Bank of Canada Expected to Cut, But Inflationary Pressures Remain a Concern -- Market Talk

5 Sept 2025, 16:39 UTC

Acquisitions, Mergers, Takeovers

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

5 Sept 2025, 16:39 UTC

Acquisitions, Mergers, Takeovers

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

5 Sept 2025, 16:39 UTC

Acquisitions, Mergers, Takeovers

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

5 Sept 2025, 16:39 UTC

Acquisitions, Mergers, Takeovers

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

5 Sept 2025, 16:37 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

5 Sept 2025, 16:37 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Energy Roundup: Market Talk

5 Sept 2025, 16:37 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Strathcona Buys Up More MEG Shares In Effort to Scuttle Cenovus Deal -- Market Talk

5 Sept 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

5 Sept 2025, 16:16 UTC

Earnings

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Guidewire, and More -- Barrons.com

5 Sept 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

Peer Comparison

Price change

BioArctic AB Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
help-icon Live chat